IIM
LAB icon

INTECH Investment Management’s Standard BioTools LAB Stock Holding History

INTECH Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.3K Sell
63,430
-58,334
-48% -$70.6K ﹤0.01% 1989
2025
Q4 		$156K Sell
121,764
-14,377
-11% -$19.3K ﹤0.01% 2057
2025
Q3 		$177K Sell
136,141
-12,877
-9% -$16.9K ﹤0.01% 2110
2025
Q2 		$179K Buy
149,018
+8,519
+6% +$9.44K ﹤0.01% 2129
2025
Q1 		$152K Buy
140,499
+32,491
+30% +$45.6K ﹤0.01% 2190
2024
Q4 		$189K Buy
108,008
+55,783
+107% +$104K ﹤0.01% 2053
2024
Q3 		$101K Buy
+52,225
New +$102K ﹤0.01% 1879

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

INTECH Investment Management's LAB Position: Q1 2026 in Review

INTECH Investment Management reduced its Standard BioTools (LAB) stake by 48% in Q1 2026, selling an estimated $70.6K and leaving 63,430 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

INTECH Investment Management first reported a position in LAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $189K in Q4 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • INTECH Investment Management held 63,430 shares of Standard BioTools worth $58.3K as of Q1 2026.
  • INTECH Investment Management sold 58,334 Standard BioTools shares in Q1 2026, an estimated $70.6K.
  • Standard BioTools made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1989 holding.
  • INTECH Investment Management first reported a position in Standard BioTools in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Standard BioTools position peaked at $189K in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.